171 related articles for article (PubMed ID: 34128129)
21. Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters.
Yang X; Mei T; Yu M; Gong Y
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):409-419. PubMed ID: 35747920
[TBL] [Abstract][Full Text] [Related]
22. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
[TBL] [Abstract][Full Text] [Related]
23. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for radiation pneumonitis after stereotactic radiation therapy for lung tumours: clinical usefulness of the planning target volume to total lung volume ratio.
Ueyama T; Arimura T; Takumi K; Nakamura F; Higashi R; Ito S; Fukukura Y; Umanodan T; Nakajo M; Koriyama C; Yoshiura T
Br J Radiol; 2018 Jun; 91(1086):20170453. PubMed ID: 29565649
[TBL] [Abstract][Full Text] [Related]
25. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
26. The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy.
Chen F; Niu J; Wang M; Zhu H; Guo Z
Radiat Oncol; 2024 May; 19(1):67. PubMed ID: 38816745
[TBL] [Abstract][Full Text] [Related]
27. A Novel Nomogram and Risk Classification System Predicting Radiation Pneumonitis in Patients With Esophageal Cancer Receiving Radiation Therapy.
Wang L; Liang S; Li C; Sun X; Pang L; Meng X; Yu J
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1074-1085. PubMed ID: 31461673
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
Lee YH; Choi HS; Jeong H; Kang KM; Song JH; Lee WS; Lee GW; Song HN; Kim HG; Kang MH; Rhee DY; Jeong BK
Clin Respir J; 2018 Mar; 12(3):1264-1273. PubMed ID: 28618180
[TBL] [Abstract][Full Text] [Related]
29. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
Ren XJ; Wang L; Han C; Liu LL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
[No Abstract] [Full Text] [Related]
30. Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study.
Jang JY; Kim SS; Song SY; Kim YJ; Kim SW; Choi EK
Radiat Oncol; 2021 Dec; 16(1):231. PubMed ID: 34863244
[TBL] [Abstract][Full Text] [Related]
31. Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy.
Yang LT; Zhou L; Chen L; Liang SX; Huang JQ; Zhu XD
Med Sci Monit; 2021 May; 27():e930515. PubMed ID: 33953150
[TBL] [Abstract][Full Text] [Related]
32. A Novel Nomogram Model Based on Cone-Beam CT Radiomics Analysis Technology for Predicting Radiation Pneumonitis in Esophageal Cancer Patients Undergoing Radiotherapy.
Du F; Tang N; Cui Y; Wang W; Zhang Y; Li Z; Li J
Front Oncol; 2020; 10():596013. PubMed ID: 33392091
[TBL] [Abstract][Full Text] [Related]
33. Subjective Global Assessment (SGA) Score Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients With Normal Pulmonary Function Treated by Intensity-Modulated Radiation Therapy and Concurrent Chemotherapy.
Ma L; Ye W; Li Q; Wang B; Luo G; Chen Z; Guo S; Qiu B; Liu H
Clin Lung Cancer; 2018 Mar; 19(2):e211-e217. PubMed ID: 29017827
[TBL] [Abstract][Full Text] [Related]
34. Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy.
Dang J; Li G; Ma L; Diao R; Zang S; Han C; Zhang S; Yao L
Acta Oncol; 2013 Aug; 52(6):1175-80. PubMed ID: 23198719
[TBL] [Abstract][Full Text] [Related]
35. Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning.
Luna JM; Chao HH; Diffenderfer ES; Valdes G; Chinniah C; Ma G; Cengel KA; Solberg TD; Berman AT; Simone CB
Radiother Oncol; 2019 Apr; 133():106-112. PubMed ID: 30935565
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors for radiation pneumonitis in oesophageal cancer patients treated with chemoradiotherapy without prophylactic nodal irradiation.
Nomura M; Kodaira T; Furutani K; Tachibana H; Tomita N; Goto Y
Br J Radiol; 2012 Jun; 85(1014):813-8. PubMed ID: 22253344
[TBL] [Abstract][Full Text] [Related]
37. Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer treated with volumetric modulated arc therapy: a retrospective study.
Yang S; Huang S; Ye X; Xiong K; Zeng B; Shi Y
BMC Pulm Med; 2022 Nov; 22(1):402. PubMed ID: 36344945
[TBL] [Abstract][Full Text] [Related]
38. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.
Tsujino K; Hirota S; Endo M; Obayashi K; Kotani Y; Satouchi M; Kado T; Takada Y
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):110-5. PubMed ID: 12504042
[TBL] [Abstract][Full Text] [Related]
40. Analysis of dose-volume parameters predicting radiation pneumonitis in patients with esophageal cancer treated with 3D-conformal radiation therapy or IMRT.
Kumar G; Rawat S; Puri A; Sharma MK; Chadha P; Babu AG; Yadav G
Jpn J Radiol; 2012 Jan; 30(1):18-24. PubMed ID: 22160648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
